BENLYSTA - belimumab
Navigation: NDC > Supplier starting with: H > HUMAN GENOME SCIENCES, INC.| Field | Value |
|---|---|
| NDC Code: | 49401-101 |
| Proprietary Name: | BENLYSTA |
| Suffix: | |
| Non-Proprietary Name: | belimumab |
| Dosage Form: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Method: | INTRAVENOUS |
| Original Marketing Date: | 10-03-2011 |
| Category Name: | BLA |
| Application Number: | BLA125370 |
| Labeler: | HUMAN GENOME SCIENCES, INC. |
| Substance Name: | BELIMUMAB |
| Active Numerator Strength: | 120 |
| Active Ingredient Unit: | mg/1.5mL |
| Pharm Classes: | Decreased B Lymphocyte Activation [PE],B Lymphocyte Stimulator-specific Inhibitor [EPC],B Lymphocyte Stimulator-directed Antibody Interactions [MoA] |
| DEA Schedule: |